Clinical Trials on SARS-CoV-2 Coronavirus in Taiwan

Total 7 results

Chimei Medical Center

Completed

Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy

Reactive Axillary Lymphadenopathy for SARS-CoV-2 Vaccines in the Asian Taiwanese Population

Taiwan
National Research Institute of Chinese Medicine...

Recruiting

The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection

SARS-CoV-2 | Covid 19

Taiwan
National Taiwan University Hospital

Completed

Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19 (LT-COVID19)

Covid19 | SARS-CoV 2 Infection

Taiwan
Senhwa Biosciences, Inc.

Not yet recruiting

Phase II, Double Blind, Randomized Trial of CX-4945 in Viral Community Acquired Pneumonia

Community-acquired Pneumonia | Influenza With Pneumonia | SARS-CoV-2 -Associated Pneumonia

Taiwan
AstraZeneca

Active, not recruiting

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study (SUPERNOVA)

COVID-19, SARS-CoV-2

United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates
Sheng-Teng Huang

Completed

Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.

Coronavirus Disease 2019 | Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Taiwan
Taipei Medical University
Taipei Medical University WanFang Hospital

Completed

Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic

Type 2 Diabetes

Taiwan

Clinical Trials on SARS-CoV-2 Coronavirus in Taiwan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations